Wednesday, Oct 28, 2026
Focus on the big picture

Lilly to seek accelerated FDA approval for Alzheimer's drug this year

Reuters, 24 Jun 2021
Eli Lilly said on Thursday it will apply for U.S. health regulator's accelerated approval this year for its experimental Alzheimer's drug, weeks after Biogen Inc's (BIIB.O) controversial drug for the disease was approved.

#EliLilly #Alzheimer #FDA #News #Reuters

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Related Articles